The Future of Clinical Trials: Decentralized, Diversified, Efficient and Fast
Oct 28, 2020•24 min•Ep. 22
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The race to develop a COVID-19 vaccine has put the clinical trial process under the microscope. Cain Brothers Managing Director, John Kerins, talks with Dave Johnson about innovations in clinical trials that reduce the barriers to participation, improve the diversity of patient populations, and accelerate the development of safe and effective vaccines.
Cain Brothers is a division of KeyBanc Capital Markets.
For the best experience, listen in Metacast app for iOS or Android